A multifunctional protease inhibitor to regulate endolysosomal function

ACS Chemical Biology

Volumn 6, Issue 11, 2011, Pages 1198-1204

  Van Kasteren, Sander I ^a,b   Berlin, Ilana ^b   Colbert, Jeff D ^a   Keane, Doreen ^a   Ovaa, Huib ^b   Watts, Colin ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYSTATIN C; PEPSTATIN; PROTEINASE INHIBITOR;

ARTICLE; ENDOSOME; ENZYME ACTIVITY; ENZYME SYNTHESIS; LYSOSOME; NONHUMAN; PRIORITY JOURNAL;

CYSTATINS; CYSTEINE PROTEASES; ENDOPEPTIDASES; LYSOSOMES; PEPSTATINS; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 81555214610     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200292c     Document Type: Article

References (43)

1. Leung, D., Abbenante, G., and Fairlie, D. P. (2000) Protease inhibitors: Current status and future prospects J. Med. Chem. 43, 305-341 (Pubitemid 30102072)
2. Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J. L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., San-Miguel, J. F., Bladé, J., Boccadoro, M., Cavenagh, J., Dalton, W. S., Boral, A. L., Esseltine, D. L., Porter, J. B., Schenkein, D., and Anderson, K. C. (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma New Engl. J. Med. 352, 2487-2498 (Pubitemid 41007864)
3. Reiser, J., Adair, B., and Reinheckel, T. (2010) Specialized roles for cysteine cathepsins in health and disease J. Clin. Invest 120, 3421-3431
4. Doyle, P. S., Sajid, M., O'Brien, T., DuBois, K., Engel, J. C., Mackey, Z. B., and Reed, S. (2008) Drugs targeting parasite lysosomes Curr. Pharm. Design 14, 889-900 (Pubitemid 351736421)
5. Palermo, C. and Joyce, J. A. (2008) Cysteine cathepsin proteases as pharmacological targets in cancer Trends Pharmacol. Sci. 29, 22-28
6. Briggs, J. J., Haugen, M. H., Johansen, H. T., Riker, A. I., Abrahamson, M., Fodstad, O., Maelandsmo, G. M., and Solberg, R. (2010) Cystatin E/M suppresses legumain activity and invasion of human melanoma BMC Cancer 10
7. Patel, N., Krishnan, S., Offman, M. N., Krol, M., Moss, C. X., Leighton, C., van Delft, F. W., Holland, M., Liu, J. Z., Alexander, S., Dempsey, C., Ariffin, H., Essink, M., Eden, T. O. B., Watts, C., Bates, P. A., and Saha, V. (2009) A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase J. Clin. Invest 119, 1964-1973
8. Liu, Z. X., Jang, S. W., Liu, X., Cheng, D. M., Peng, J., Yepes, M., Li, X. J., Matthews, S., Watts, C., Asano, M., Hara-Nishimura, I., Luo, H. R., and Ye, K. Q. (2008) Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase Mol. Cell 29, 665-678 (Pubitemid 351400928)
9. Keppler, D. (2006) Towards novel anti-cancer strategies based on cystatin function Cancer Lett. 235, 159-176
10. Henskens, Y. M., Veerman, E. C., and Nieuw Amerongen, A. V. (1996) Cystatins in health and disease Biol. Chem. 377, 71-86 (Pubitemid 26089038)
11. Nicotra, G., Manfroi, F., Follo, C., Castino, R., Fusco, N., Peracchio, C., Kerim, S., Valente, G., and Isidoro, C. (2010) High expression of cathepsin D in non-Hodgkin's lymphomas negatively impacts on clinical outcome Dis. Markers 28, 167-183
12. Liaudet-Coopman, E., Beaujouin, M., Derocq, D., Garcia, M., Glondu-Lassis, M., Laurent-Matha, V., Prebois, C., Rochefort, H., and Vignon, F. (2006) Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis Cancer Lett. 237, 167-179 (Pubitemid 43777078)
13. Delamarre, L., Couture, R., Mellman, I., and Trombetta, E. S. (2006) Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis J. Exp. Med. 203, 2049-2055 (Pubitemid 44352226)
14. Moss, C. X., Villadangos, J. A., and Watts, C. (2005) Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing Eur. J. Immunol. 35, 3442-3451 (Pubitemid 43025525)
15. Matthews, S. P., Werber, I., Deussing, J., Peters, C., Reinheckel, T., and Watts, C. (2010) Distinct protease requirements for antigen presentation in vitro and in vivo J. Immunol. 184, 2423-2431
16. Dennemärker, J., Lohmüller, T., Müller, S., Aguilar, S. V., Tobin, D. J., Peters, C., and Reinheckel, T. (2010) Impaired turnover of autophagolysosomes in cathepsin L deficiency Biol. Chem. 391, 913-922
17. Bednarski, E., Ribak, C. E., and Lynch, G. (1997) Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus J. Neurosci. 17, 4006-4021 (Pubitemid 27220591)
18. Turk, B., Turk, D., and Turk, V. (2000) Lysosomal cysteine proteases: More than scavengers Biochim. Biophys. Act. 1477, 98-111 (Pubitemid 30119895)
19. Manoury, B., Hewitt, E. W., Morrice, N., Dando, P. M., Barrett, A. J., and Watts, C. (1998) An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation Nature 396, 695-699 (Pubitemid 29003950)
20. Otto, H.-H. and Schirmeister, T. (1997) Cysteine proteases and their inhibitors Chem. Rev. 97, 133-172
21. Rozman-Pungercar, J., Kopitar-Jerala, N., Bogyo, M., Turk, D., Vasiljeva, O., Stefe, I., Vandenabeele, P., Bromme, D., Puizdar, V., Fonovi, M., Trstenjak-Prebanda, M., Dolenc, I., Turk, V., and Turk, B. (2003) Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity Cell Death Differ. 10, 881-888 (Pubitemid 36939698)
22. Abrahamson, M., Alvarez-Fernandez, M., and Nathanson, C. M. (2003) Cystatins Biochem. Soc. Symp. 179-199 (Pubitemid 38497225)
23. Alvarez-Fernandez, M., Barrett, A. J., Gerhartz, B., Dando, P. M., Ni, J., and Abrahamson, M. (1999) Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site J. Biol. Chem. 274, 19195-19203
24. Umezawa, H., Aoyagi, T., Morishima, H., Matsuzaki, M., and Hamada, M. (1970) Pepstatin, a new pepsin inhibitor produced by Actinomycetes J. Antibiot. 23, 259-262
25. Furuno, K., Miwa, N., and Kato, K. (1983) Receptor-mediated introduction of pepstatin-asialofetuin conjugate into lysosomes of rat hepatocytes J. Biochem. 93, 249-256 (Pubitemid 13003247)
26. Brygier, J., Vlncentelli, J., Nljs, M., Guermant, C., Paul, C., Baeyens-Volant, D., and Looze, Y. (1994) Preparation and preliminary characterization of poly(ethylene glycol)-pepstatin conjugate Appl. Biochem. Biotechnol. 47, 1-10
27. Free, P., Hurley, C. A., Kageyama, T., Chain, B. M., and Tabor, A. B. (2006) Mannose-pepstatin conjugates as targeted inhibitors of antigen processing Org. Biomol. Chem. 4, 1817-1830 (Pubitemid 43835202)
28. Raiber, E. A., Tulone, C., Zhang, Y., Martinez-Pomares, L., Steed, E., Sponaas, A. M., Langhorne, J., Noursadeghi, M., Chain, B. M., and Tabor, A. B. (2010) Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors ACS Chem. Biol. 5, 461-476
29. Chen, C. S., Chen, W. N. U., Zhou, M., Arttamangkul, S., and Haugland, R. P. (2000) Probing the cathepsin D using a BODIPY FL-pepstatin A: Applications in fluorescence polarization and microscopy J. Biochem. Biophys. Methods 42, 137-151 (Pubitemid 30100551)
30. Zaidi, N., Burster, T., Sommandas, V., Herrmann, T., Boehm, B. O., Driessen, C., Voelter, W., and Kalbacher, H. (2007) A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A Biochem. Biophys. Res. Commun. 364, 243-249 (Pubitemid 47633408)
31. Hsing, L. C. and Rudensky, A. Y. (2005) The lysosomal cysteine proteases in MHC class II antigen presentation Immunol. Rev. 207, 229-241 (Pubitemid 41415021)
32. Chalker, J. M., Bernardes, G. J. L., Lin, Y. A., and Davis, B. G. (2009) Chemical modification of proteins at cysteine: Opportunities in chemistry and biology Chem.-Asian J. 4, 630-640
33. van Kasteren, S. I., Garnier, P. G., and Davis, B. G. (2007) Chemical methods for mimicking post-translational modification, in Protein Engineering, Springer Verlag, New York.
34. Kenyon, G. L. and Bruice, T. W. (1977) Novel sulfhydryl reagents Methods Enzymol. 47, 407-430
35. Singh, R. and Cresswell, P. (2010) Defective cross-presentation of viral antigens in GILT-free mice Science 328, 1394-1398
36. Jones, L. J., Upson, R. H., Haugland, R. P., PanchukVoloshina, N., and Zhou, M. J. (1997) Quenched BODIPY dye-labeled casein substrates for the assay of protease activity by direct fluorescence measurement Anal. Biochem. 251, 144-152 (Pubitemid 27392671)
37. Moss, C. X., Villadangos, J. A., and Watts, C. (2005) Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing Eur. J. Immunol. 35, 3442-3451 (Pubitemid 43025525)
38. Vieira, A. V., Lamaze, C., and Schmid, S. L. (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis Science 274, 2086-2089 (Pubitemid 27020702)
39. Katzmann, D. J., Odorizzi, G., and Emr, S. D. (2002) Receptor downregulation and multivesicular-body sorting Nat. Rev. Mol. Cell Biol. 3, 893-905 (Pubitemid 35477368)
40. Berlin, I., Higginbotham, K. M., Dise, R. S., Sierra, M. I., and Nash, P. D. (2010) The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome J. Biol. Chem. 285, 37895-37908
41. Ciechanover, A., Schwartz, A. L., Dautry-Varsat, A., and Lodish, H. F. (1983) Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents J. Biol. Chem. 258, 9681-9689 (Pubitemid 13049101)
42. Berlin, I., Schwartz, H., and Nash, P. D. (2010) Regulation of the epidermal growth factor receptor ubiquitination and trafficking by the USP8/STAM complex J. Biol. Chem. 285 (48) 37895-37908
43. Auerswald, E. A., Nagler, D. K., Assfalgmachleidt, I., Stubbs, M. T., Machleidt, W., and Fritz, H. (1995) Hairpin loop mutations of chicken cystatin have different effects on the inhibition of Cathepsin B, Cathepsin L and Papain FEBS Lett. 361, 179-184